XBI
ETF
Biotechnology
NYSEARCA
SPDR S&P Biotech ETF
$128.55
+0.82 (+0.64%)
Fund Overview
by SPDR (State Street)
Equal-weighted biotech ETF. Gives small-cap clinical-stage biotech companies equal weight with large-cap pharma-like biotechs, creating a higher risk/reward profile. When biotech M&A heats up, XBI often outperforms.
AUM$6.5B
Expense Ratio0.35%
Holdings145
Dividend Yield0.1%
DistributionQuarterly
BenchmarkS&P Biotechnology Select Industry Index
InceptionJan 2006
ExchangeNYSEARCA
Price Data
Open$128.79
Prev Close$127.73
Day Range$128.03 — $131.45
52W Range$66.66 — $132.09
52-Week Range
$66.66
$132.09
From 52W High
-2.7%
From 52W Low
+92.8%
Investment Calculator
See how much dividend income XBI could generate based on its current price of $128.55 and 0.1% yield. Adjust the amount to estimate your quarterly distributions.
$
Shares Purchased
Amount Invested$9,898.35
Annual Income$9.90
Monthly Income$0.82
Based on current dividend yield of 0.1%. Actual distributions may vary. Past dividends do not guarantee future payments.
Biotechnology ETF Comparison
Top Biotechnology Stocks
View all →
| Stock | Price | Change | Market Cap |
|---|---|---|---|
| ABBV | $206.69 | -1.03% | 369.26B |
| AMGN | $342.57 | -1.54% | 190.40B |
| GILD | $140.13 | +0.30% | 166.66B |
| VRTX | $434.30 | -1.01% | 114.87B |
| REGN | $763.04 | +0.16% | 80.50B |
| ALNY | $330.34 | +3.60% | 42.29B |
| INSM | $163.81 | +0.85% | 35.01B |
| NTRA | $204.87 | -1.50% | 29.48B |
| BIIB | $172.34 | -2.82% | 26.03B |
| UTHR | $559.65 | -0.91% | 24.75B |
XBI FAQ
What is XBI?
XBI is the SPDR S&P Biotech ETF, an exchange-traded fund managed by SPDR (State Street). It tracks the S&P Biotechnology Select Industry Index and holds 145 Biotechnology securities with an expense ratio of 0.35%.
What is the expense ratio of XBI?
XBI charges an annual expense ratio of 0.35%, which means you pay $35.00 per year for every $10,000 invested. This fee is deducted automatically from the fund's returns.
Does XBI pay dividends?
Yes, XBI pays a 0.1% dividend yield, distributed quarterly. On a $10,000 investment, that works out to approximately $10.00 per year in dividend income.
Explore Biotechnology Stocks
View our full list of individual biotechnology stocks with prices, fundamentals, and analyst ratings.
Last updated: Apr 1, 2026 at 10:14 PM ET